Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Cell characteristics change with passage numbers, affecting experiment results.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Stereotactic body radiation therapy and radiosurgery are advanced, precise treatments that target tumors while protecting healthy tissue.

Pomegranate leaves can be a cost-effective source of beneficial ingredients for health and skincare products.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.